Patient Pathfinder: Clinical Trials
Clinical Trials for Myelodysplastic Syndrome
Every life-saving or life-extending treatment that’s available today started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand Myelodysplastic Syndrome (MDS), and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 165 active Myelodysplastic Syndrome trials
Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
Study Type: Interventional Phase 2
Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors
Study Type: Interventional Phase 1
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
Study Type: Interventional Phase 2
Natural History Study of GATA2 Deficiency and Related Disorders
Study Type: Observational
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Study Type: Interventional Phase 3
Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis
Study Type: Interventional Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
Study Type: Interventional Phase 2
Study of R289 in Participants With Lower-risk Myelodysplastic Syndromes (LR MDS)
Study Type: Interventional Phase 1
There are 165 active Myelodysplastic Syndrome trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now